Rapid Micro Biosystems, Inc.
RPID
$2.46
$0.187.90%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 29.68% | 23.74% | 32.31% | 11.44% | 44.88% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 29.68% | 23.74% | 32.31% | 11.44% | 44.88% |
Cost of Revenue | 11.18% | -10.21% | -1.26% | 4.53% | -6.68% |
Gross Profit | 670.35% | 138.14% | 90.01% | 14.92% | 93.39% |
SG&A Expenses | -10.23% | -6.70% | -4.87% | -10.28% | -22.73% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -0.42% | -4.62% | -0.30% | -0.12% | -14.37% |
Operating Income | 16.07% | 16.68% | 11.13% | 4.03% | 29.39% |
Income Before Tax | 13.34% | 15.48% | 10.33% | 4.04% | 32.09% |
Income Tax Expenses | -212.50% | 30.00% | 150.00% | -57.14% | 14.29% |
Earnings from Continuing Operations | 13.48% | 15.45% | 10.26% | 4.07% | 32.07% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 13.48% | 15.45% | 10.26% | 4.07% | 32.07% |
EBIT | 16.07% | 16.68% | 11.13% | 4.03% | 29.39% |
EBITDA | 16.97% | 17.34% | 12.74% | 4.55% | 30.52% |
EPS Basic | 14.75% | 16.60% | 11.40% | 5.02% | 32.92% |
Normalized Basic EPS | 14.53% | 16.59% | 11.50% | 4.99% | 32.96% |
EPS Diluted | 14.75% | 16.60% | 11.40% | 5.02% | 32.92% |
Normalized Diluted EPS | 14.53% | 16.59% | 11.50% | 4.99% | 32.96% |
Average Basic Shares Outstanding | 1.46% | 1.37% | 1.29% | 1.01% | 1.26% |
Average Diluted Shares Outstanding | 1.46% | 1.37% | 1.29% | 1.01% | 1.26% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |